Moderna has announced its Q2 2021 financial details, as well as information about its COVID-19 vaccine trials and plans going forward. Among other things, the company talked about its vaccine’s efficacy after six months, as well as vaccine booster candidates and the promise they show against concerning SARS-CoV-2 variants. According to Moderna, its COVID-19 vaccine remains 93-percent effective after six …
Moderna has announced its Q2 2021 financial details, as well as information about its COVID-19 vaccine trials and plans going forward. Among other things, the company talked about its vaccine’s efficacy after six months, as well as vaccine booster candidates and the promise they show against concerning SARS-CoV-2 variants. According to Moderna, its COVID-19 vaccine remains 93-percent effective after six …
Share this Article
Recommended